Gerresheimer AG Net Assets
Gerresheimer AG net assets. Based on the latest financial reports, Gerresheimer AG (GXI) has net assets worth €1.47 Billion EUR (≈ $1.71 Billion USD) as of May 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.76 Billion ≈ $5.56 Billion USD) and total liabilities (€3.29 Billion ≈ $3.85 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Gerresheimer AG (GXI) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.47 Billion |
| % of Total Assets | 30.83% |
| Annual Growth Rate | 9.57% |
| 5-Year Change | 71.08% |
| 10-Year Change | 120.47% |
| Growth Volatility | 7.75 |
Net Assets of Gerresheimer AG (2013–2024)
Net assets of Gerresheimer AG from 2013 to 2024. This chart illustrates how Gerresheimer AG's net assets have evolved over time, based on quarterly financial data. See Gerresheimer AG net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Gerresheimer AG (2013–2024)
The table below shows the annual net assets of Gerresheimer AG from 2013 to 2024. For live market cap and overall valuation, see market cap of Gerresheimer AG.
| Year | Net Assets | Change |
|---|---|---|
| 2024-11-30 | €1.54 Billion ≈ $1.80 Billion |
+4.54% |
| 2023-11-30 | €1.47 Billion ≈ $1.72 Billion |
+15.99% |
| 2022-11-30 | €1.27 Billion ≈ $1.48 Billion |
+26.66% |
| 2021-11-30 | €1.00 Billion ≈ $1.17 Billion |
+11.40% |
| 2020-11-30 | €899.66 Million ≈ $1.05 Billion |
-4.45% |
| 2019-11-30 | €941.56 Million ≈ $1.10 Billion |
+5.78% |
| 2018-11-30 | €890.13 Million ≈ $1.04 Billion |
+12.74% |
| 2017-11-30 | €789.52 Million ≈ $923.04 Million |
+3.44% |
| 2016-11-30 | €763.29 Million ≈ $892.37 Million |
+9.33% |
| 2015-11-30 | €698.13 Million ≈ $816.19 Million |
+15.51% |
| 2014-11-30 | €604.37 Million ≈ $706.57 Million |
+7.27% |
| 2013-11-30 | €563.40 Million ≈ $658.68 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Gerresheimer AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 75272400000.0% over the analyzed period, indicating profitable operations and earnings retention.
Gerresheimer AG Net Assets Breakdown (November 2024)
Gerresheimer AG net assets breakdown by equity component as of November 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €746.21 Million | 49.37% |
| Other Components | €765.35 Million | 50.63% |
| Total Equity | €1.51 Billion | 100.00% |
Gerresheimer AG Competitors by Market Cap
The table below lists competitors of Gerresheimer AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hangzhou XZB Tech Co Ltd
SHG:603040
|
$711.05 Million |
|
Guangdong Meiyan Jixiang Hydropower Co Ltd
SHG:600868
|
$711.06 Million |
|
Zhejiang Baoxiniao Garment Co Ltd
SHE:002154
|
$711.11 Million |
|
IPH Ltd
AU:IPH
|
$711.16 Million |
|
Ridley Corporation Ltd
AU:RIC
|
$710.82 Million |
|
GRIPM Advanced Materials Co. Ltd. A
SHG:688456
|
$710.65 Million |
|
Vulcabras Azaleia S.A
SA:VULC3
|
$710.65 Million |
|
Arrow Financial Corporation
NASDAQ:AROW
|
$710.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gerresheimer AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,445,660,000 to 1,511,562,000, a change of 65,902,000 (4.6%).
- Net income of 109,720,000 contributed positively to equity growth.
- Other factors decreased equity by 43,818,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €109.72 Million | +7.26% |
| Other Changes | €-43.82 Million | -2.9% |
| Total Change | €- | 4.56% |
Book Value vs Market Value Analysis
This analysis compares Gerresheimer AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.75x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.38x to 0.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-11-30 | €23.98 | €33.04 | x |
| 2018-11-30 | €27.79 | €33.04 | x |
| 2019-11-30 | €29.46 | €33.04 | x |
| 2020-11-30 | €28.15 | €33.04 | x |
| 2021-11-30 | €31.25 | €33.04 | x |
| 2022-11-30 | €39.58 | €33.04 | x |
| 2023-11-30 | €41.85 | €33.04 | x |
| 2024-11-30 | €43.76 | €33.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gerresheimer AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.26%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.39%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 2.52x
- Recent ROE (7.26%) is below the historical average (11.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 12.29% | 4.91% | 0.78x | 3.19x | €11.57 Million |
| 2014 | 12.21% | 5.14% | 0.78x | 3.05x | €11.99 Million |
| 2015 | 16.64% | 8.12% | 0.53x | 3.86x | €41.58 Million |
| 2016 | 16.75% | 8.84% | 0.58x | 3.27x | €49.02 Million |
| 2017 | 13.40% | 7.48% | 0.55x | 3.25x | €25.58 Million |
| 2018 | 14.78% | 9.43% | 0.50x | 3.13x | €41.70 Million |
| 2019 | 8.73% | 5.80% | 0.53x | 2.86x | €-11.73 Million |
| 2020 | 10.02% | 6.24% | 0.54x | 2.96x | €175.70K |
| 2021 | 8.54% | 5.59% | 0.52x | 2.93x | €-14.34 Million |
| 2022 | 7.73% | 5.29% | 0.54x | 2.70x | €-28.17 Million |
| 2023 | 8.03% | 5.83% | 0.58x | 2.37x | €-28.44 Million |
| 2024 | 7.26% | 5.39% | 0.53x | 2.52x | €-41.44 Million |
Industry Comparison
This section compares Gerresheimer AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $5,548,175,105
- Average return on equity (ROE) among peers: -88.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gerresheimer AG (GXI) | €1.47 Billion | 12.29% | 2.24x | $710.83 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $4.02 Billion | 4.35% | 1.05x | $17.02 Billion |
| MEDIMI AB AK (79T) | $332.69K | -959.52% | 4.12x | $1.70 Million |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-736.70K | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $1.13 Billion | 12.86% | 0.83x | $1.05 Billion |
| Carl Zeiss Meditec AG (AFX) | $1.24 Billion | 10.83% | 0.31x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.06 Billion | 8.69% | 0.65x | $2.14 Billion |
| Bio-gate AG (BIG1) | $3.45 Million | -46.99% | 0.52x | $7.12 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $8.17 Billion | 59.07% | 0.94x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $38.15 Billion | 5.64% | 0.59x | $67.43 Billion |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more